Anzeige
Mehr »
Mittwoch, 06.08.2025 - Börsentäglich über 12.000 News
US-Kupfer-Geheimtipp legt nach: Strategisches Projekt zündet Phase 2 mit KI-Bohrplanung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QB92 | ISIN: US74737V2051 | Ticker-Symbol:
Branche
Getränke/Tabak
Aktienmarkt
Sonstige
1-Jahres-Chart
PYXUS INTERNATIONAL INC Chart 1 Jahr
5-Tage-Chart
PYXUS INTERNATIONAL INC 5-Tage-Chart
PR Newswire
21 Leser
Artikel bewerten:
(0)

Pyxus International, Inc. Reports First Quarter Fiscal 2026 Results; Reiterates Full-Year Guidance

MORRISVILLE, N.C., Aug. 6, 2025 /PRNewswire/ -- Pyxus International, Inc. (OTCID: PYYX) ("Pyxus," the "Company," "we," or "our"), a global value-added agricultural company, today announced results for its first quarter ended June 30, 2025.

Pieter Sikkel, Pyxus' President and Chief Executive Officer, said, "We are pleased to report first quarter results that align with our financial expectations and position the business to achieve our full-year guidance for fiscal 2026. These results reflect a more normalized cycle-buying in the first half of the fiscal year and selling in the second half-improving our alignment with customer requirements and generating further efficiencies for the business.

"During the quarter, we effectively navigated a highly dynamic and competitive market to capture buying opportunities generated by record crop sizes in South America and Africa. The additional volumes purchased support our ability to satisfy continued strong customer demand and deliver shareholder value. We expect this impact to be increasingly visible in the second half, reinforcing our outlook for another strong fiscal year."

First Quarter Fiscal 2026 Results

First quarter sales and other operating revenues were $508.8 million compared to $634.9 million for the prior year's first quarter. This result was expected and largely related to the acceleration of certain customer shipments into the fourth quarter of fiscal year 2025. This was partially offset by higher pricing per kilogram.

Cost of goods and services sold was $443.2 million for the three months ended June 30, 2025, compared to $551.0 million for the same quarter in fiscal year 2025. This reduction was consistent with the change in sales and other operating revenues.

Gross profit as a percent of sales was 12.9% in the first quarter of fiscal year 2026 compared to 13.2% for the same period in the prior year. This was driven by regional and customer mix for leaf sales, which was partially offset by an increase in processing and other gross profit.

Selling, general, and administrative expenses in the first quarter remained well managed and improved slightly to $40.4 million compared to $40.7 million in the first quarter of fiscal 2025.

The Company's operating income was $21.0 million as compared to $40.5 million in the first quarter of fiscal 2025. Net (loss) income attributable to Pyxus International, Inc. in the first quarter was $(15.8) million as compared to $4.6 million in the first quarter of the prior fiscal year. Adjusted EBITDA in the first quarter was $29.5 million compared to $55.0 million in the same quarter of the prior fiscal year. Each of these fluctuations was driven by factors consistent with lower sales and gross profit.

Select Balance Sheet and Liquidity Information

As of June 30, 2025, the balance sheet reflected a more normalized cadence in the business compared to the short-crop conditions experienced in the prior fiscal year, particularly with respect to larger crop purchases, mainly in Africa. Additionally, the Company's total net debt, which increased by $90.3 million versus the prior year, compared favorably with the year-over-year inventory increase of $107.3 million.

Tobacco inventory at the end of the first quarter was $1,089.8 million compared to $980.6 million at the same time last year, which reflects larger crop availability in the market. Uncommitted inventory at June 30, 2025 was $13.6 million, or 2.4% of the $575.9 million in total processed inventory, compared to $14.7 million of uncommitted inventory and total processed inventory of $605.5 million held at June 30, 2024.

Uncommitted levels of processed tobacco remain low due to strong demand from our customers. While undersupply conditions have persisted in the global tobacco market in recent periods, the larger crops experienced in Africa and South America this buying season are anticipated to provide a more balanced global leaf market.

The Company continued to improve its cash conversion, reducing average operating cycle time to 160 days in the first quarter compared to 172 days in the same period last fiscal year, contributing to improved efficiency and availability.

Reiterated Guidance for Fiscal Year

The Company's first quarter results were in-line with its internal expectations, and it continues to anticipate for the full fiscal year that it will report sales in the range of $2.3 billion to $2.5 billion and adjusted EBITDA in the range of $205 million to $235 million.

Financial Results Investor Call

The Company will hold an earnings conference call and webcast on August 6, 2025, at 9 a.m. EDT. Investors and analysts interested in participating in the call are invited to dial (929) 477-0448 or (888) 254-3590 and use conference ID 8412361. The webcast can be accessed at http://investors.pyxus.com.

This release, as well as the Company's first quarter results presentation, will be available on the Company's investor relations webpage prior to the call. For those unable to join the live audio webcast, an archived recording will be available on the Company's investor relations webpage shortly after the call.

Any replay, rebroadcast, transcript, or other reproduction of this conference call, other than the replay accessible by calling the number above, has not been authorized by Pyxus International and is strictly prohibited. Investors should be aware that any unauthorized reproduction of this conference call may not be an accurate reflection of its contents.

Cautionary Statement Regarding Forward-Looking Statements

Readers are cautioned that the statements contained in this report regarding expectations of our performance or other matters that may affect our business, results of operations, or financial condition are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements, which are based on current expectations of future events, may be identified by the use of words such as "guidance", "strategy," "expects," "continues," "plans," "anticipates," "believes," "will," "estimates," "intends," "projects," "goals," "targets," and other words of similar meaning. These statements also may be identified by the fact that they do not relate strictly to historical or current facts. If underlying assumptions prove inaccurate, or if known or unknown risks or uncertainties materialize, actual results could vary materially from those anticipated, estimated, or projected. These risks and uncertainties include those discussed in our Annual Report on Form 10-K for the year ended March 31, 2025, our most recent Quarterly Report on Form 10-Q, and in our other filings with the Securities and Exchange Commission. These risks and uncertainties include: our reliance on a small number of significant customers; continued vertical integration by our customers; global shifts in sourcing customer requirements, the imposition of tariffs and other changes in international trade policies; shifts in the global supply and demand position for tobacco products; variation in our financial results due to growing conditions, customer indications and other factors; loss of confidence in us by our customers, farmers and other suppliers; migration of suppliers who have historically grown tobacco and from whom we have purchased tobacco toward growing other crops; risks related to our advancement of inputs to tobacco suppliers to be settled upon the suppliers delivering us unprocessed tobacco at the end of the growing season; risks that the tobacco we purchase directly from suppliers will not meet our customers' quality and quantity requirements; weather and other environmental conditions that can affect the quantity and marketability of our inventory; international business risks, including unsettled political conditions, uncertainty in the enforcement of legal obligations, including the collection of accounts receivable, fraud risks, expropriation, import and export restrictions, exchange controls, inflationary economies, currency risks and risks related to the restrictions on repatriation of earnings or proceeds from liquidated assets of foreign subsidiaries; many of our operations are located in jurisdictions that pose a high risk of potential violations of the Foreign Corrupt Practices Act; risks and uncertainties related to geopolitical conflicts, including the conflicts in the Middle East and disruptions affecting shipping in that area; impacts of international sanctions on our ability to sell or source tobacco in certain regions; exposure to foreign tax regimes in which the rules are not clear, are not consistently applied and are subject to sudden change; fluctuations in foreign currency exchange and interest rates; competition with the other primary global independent leaf tobacco merchant and independent leaf merchants; disruption, failure or security breaches of our information technology systems and other cybersecurity risks; continued high inflation; regulations regarding environmental matters; risks related to our capital structure, including risks related to our significant debt and our ability to continue to finance our non-U.S. local operations with uncommitted short-term operating credit lines at the local level; our ability to continue to access capital markets to obtain long-term and short-term financing; potential failure of foreign banks in which our subsidiaries maintain deposits or the failure by such banks to transfer funds or honor withdrawals; the risk that, because our ability to generate cash depends on many factors beyond our control, we may be unable to generate the significant amount of cash required to service our indebtedness; our ability to refinance our current credit facilities at the same availability or at similar or reduced interest rates; failure to achieve our stated goals, which may adversely affect our liquidity; developments with respect to our liquidity needs and sources of liquidity; the volatility and disruption of global credit markets; failure by counterparties to derivative transactions to perform their obligations; increasing scrutiny and changing expectations from governments, as well as other stakeholders such as investors and customers, with respect to our environmental, social and governance policies, including sustainability policies; inherent risk of exposure to product liability claims, regulatory action and litigation facing our e-liquids business if its products are alleged to have caused significant loss, injury, or death; certain shareholders have the ability to exercise controlling influence on various corporate matters; reductions in demand for consumer tobacco products; risks and uncertainties related to pandemics or other widespread health crises and any related shipping constraints, labor shortages and supply-chain impacts; legislative and regulatory initiatives that may reduce consumption of consumer tobacco products and demand for our services and increase regulatory burdens on us or our customers; government actions that significantly affect the sourcing of tobacco, including governmental actions to identify and assess crop diversification initiatives and alternatives to leaf tobacco growing in countries whose economies depend upon tobacco production; governmental investigations into the Company's business activities, including but not limited to, leaf tobacco industry buying and other payment practices; and impact of proposed regulations to prohibit the sale of cigarettes and certain other tobacco products in the United States other than low-nicotine versions of those products. The Company does not undertake to update any forward-looking statements that we may make from time to time except to the extent required by law.

Non-GAAP Financial Information

This press release contains financial measures that have not been prepared in accordance with generally accepted accounting principles in the United States ("GAAP"). They include EBITDA, Adjusted EBITDA, Adjusted Free Cash Flow, and Net Debt. Tables showing the reconciliation of historical non-GAAP financial measures are attached to the release. The range of Adjusted EBITDA anticipated for the fiscal year ending March 31, 2026 is calculated in a manner consistent with the presentation of Adjusted EBITDA in the attached tables. Because of the forward-looking nature of the estimated range of Adjusted EBITDA, it is impractical to present a quantitative reconciliation of such measure to a comparable GAAP measure, and accordingly no such GAAP measure is being presented.

About Pyxus International, Inc.

Pyxus International, Inc. is a global agricultural company with more than 150 years of experience delivering value-added products and services to businesses and customers. Driven by a united purpose-to transform people's lives, so that together we can grow a better world-Pyxus International, its subsidiaries and affiliates, are trusted providers of responsibly sourced, independently verified, sustainable and traceable products and ingredients.

Condensed Consolidated Statements of Operations



Three Months Ended


June 30,

(in thousands, except per share data)

2025

2024

Sales and other operating revenues

$ 508,815

$ 634,855

Cost of goods and services sold

443,189

551,003

Gross profit

65,626

83,852

Selling, general, and administrative expenses

40,369

40,662

Other expense, net

4,176

2,630

Restructuring and asset impairment charges

81

103

Operating income

21,000

40,457

Gain on debt retirement

-

1,323

Interest expense, net

29,767

33,272

(Loss) income before income taxes and other items

(8,767)

8,508

Income tax expense

5,227

6,119

(Loss) income from unconsolidated affiliates, net

(1,269)

2,563

Net (loss) income

(15,263)

4,952

Net income attributable to noncontrolling interests

562

310

Net (loss) income attributable to Pyxus International, Inc.

$ (15,825)

$ 4,642




(Loss) earnings per share:



Basic

$ (0.62)

$ 0.18

Diluted

$ (0.62)

$ 0.18




Weighted average number of shares outstanding:



Basic

25,670

25,461

Diluted

25,670

25,461

Condensed Consolidated Balance Sheets


(in thousands)

June 30, 2025

June 30, 2024

Assets



Current assets



Cash and cash equivalents

$ 96,437

$ 82,042

Restricted cash

4,945

7,061

Trade receivables, net

206,607

209,053

Other receivables

16,683

17,042

Inventories, net

1,121,788

1,014,527

Advances to tobacco suppliers, net

61,737

43,863

Recoverable income taxes

11,670

4,070

Prepaid expenses

50,011

47,270

Other current assets

21,123

17,219

Total current assets

1,591,001

1,442,147

Investments in unconsolidated affiliates

95,659

103,818

Intangible assets, net

27,387

32,728

Deferred income taxes, net

13,181

8,947

Long-term recoverable income taxes

4,956

3,985

Other noncurrent assets

39,315

33,097

Right-of-use assets

32,033

33,521

Property, plant, and equipment, net

136,993

134,468

Total assets

$ 1,940,525

$ 1,792,711







Liabilities and Stockholders' Equity



Current liabilities



Notes payable

$ 880,925

$ 679,399

Accounts payable

124,341

115,312

Advances from customers

87,374

70,985

Accrued expenses and other current liabilities

104,162

99,052

Income taxes payable

10,449

8,706

Operating leases payable

9,565

7,822

Current portion of long-term debt

-

20,445

Total current liabilities

1,216,816

1,001,721

Long-term taxes payable

6,195

5,373

Long-term debt

455,091

531,461

Deferred income taxes

8,902

6,571

Liability for unrecognized tax benefits

21,935

19,257

Long-term leases

19,541

22,456

Pension, postretirement, and other long-term liabilities

57,805

52,760

Total liabilities

1,786,285

1,639,599

Commitments and contingencies



Stockholders' equity



Common Stock-no par value:



Authorized shares (250,000 for all periods)



Issued and outstanding shares (24,608 and 25,000)

393,136

392,820

Retained deficit

(255,950)

(250,649)

Accumulated other comprehensive income

10,811

6,092

Total stockholders' equity of Pyxus International, Inc.

147,997

148,263

Noncontrolling interests

6,243

4,849

Total stockholders' equity

154,240

153,112

Total liabilities and stockholders' equity

$ 1,940,525

$ 1,792,711







Segment Results


Three Months Ended June 30, 2025 and 2024


Three Months Ended June 30,




Change

(in millions, except per kilo amounts)

2025

2024

$

%

Leaf:





Product revenues

$ 458.2

$ 589.2

(131.0)

(22.2)

Tobacco costs

375.7

484.0

(108.3)

(22.4)

Transportation, storage, and other period costs

25.1

24.8

0.3

1.2

Total product cost of goods sold

400.8

508.8

(108.0)

(21.2)

Product gross profit

57.4

80.4

(23.0)

(28.6)

Product gross profit as a percent of sales

12.5 %

13.6 %








Kilos sold

66.9

95.7

(28.8)

(30.1)

Average price per kilo

$ 6.85

$ 6.16

0.69

11.2

Average cost per kilo

5.99

5.32

0.67

12.6

Average gross profit per kilo

0.86

0.84

0.02

2.4






Processing and other revenues

$ 50.2

$ 41.8

8.4

20.1

Processing and other costs of services sold

42.6

37.4

5.2

13.9

Processing and other gross profit

7.6

4.4

3.2

72.7

Processing and other gross profit as a percent of sales

15.1 %

10.5 %








All Other:





Sales and other operating revenues

$ 0.4

$ 3.9

(3.5)

(89.7)

Cost of goods and services sold

(0.2)

4.8

(5.0)

(104.2)

Gross profit (loss)

0.6

(0.9)

1.5

166.7

Gross profit (loss) as a percent of sales

150.0 %

(23.1) %




443

509

66


Reconciliation of Certain Non-GAAP Financial Measures (1) (Unaudited)



Three Months Ended

Fiscal Year Ended

Last Twelve Months (6)

(in thousands)

June 30, 2025

June 30, 2024

June 30, 2023

March 31, 2025

March 31, 2024

June 30, 2025

June 30, 2024

Net (loss) income attributable to Pyxus International, Inc.

$ (15,825)

$ 4,642

$ 804

$ 15,166

$ 2,663

(5,301)

$ 6,501

Plus: Interest expense

30,623

34,475

32,366

133,108

132,174

129,256

134,283

Plus: Income tax expense

5,227

6,119

2,646

25,053

27,281

24,161

30,754

Plus: Depreciation and amortization expense

5,169

5,127

4,606

20,334

19,250

20,376

19,771

EBITDA (1)

25,194

50,363

40,422

193,661

181,368

168,492

191,309

Plus: (Recoveries) reserves for doubtful customer receivables

(226)

157

135

103

640

(280)

662

Plus: Noncash equity-based compensation

237

3,031

-

4,110

-

1,316

3,031

Plus: Other expense, net

4,176

2,630

2,624

16,410

9,439

17,956

9,445

Plus: Restructuring and asset impairment charges (2)

81

103

40

2,259

4,799

2,237

4,862

Less: Gain on debt retirement

-

1,323

-

8,178

15,914

6,855

17,237

Plus: Debt restructuring

-

-

140

-

330

-

190

Plus: Pension retirement expense (3)

-

-

-

-

12,008

-

12,008

Plus: Other adjustments (4)

(11)

9

293

45

1,247

25

963

Adjusted EBITDA (1)

$ 29,451

$ 54,970

$ 43,654

$ 208,410

$ 193,917

$ 182,891

$ 205,233









Total debt




$ 849,892

$ 1,017,340

$ 1,336,016

$ 1,231,305

Less: Cash and cash equivalents




78,254

92,569

96,437

82,042

Net Debt (1)




$ 771,638

$ 924,771

$ 1,239,579

$ 1,149,263

Net Debt /Adjusted EBITDA (1)




3.70x

4.77x

6.78x

5.60x









Adjusted EBITDA (1)




$ 208,410

$ 193,917

$ 182,891

$ 205,233

Interest expense




133,108

132,174

129,256

134,283

Interest coverage




1.57x

1.47x

1.41x

1.53x









Net cash used in operating activities

$ (495,287)

$ (252,176)

$ (285,674)

$ (13,386)

$ (214,970)

$ (256,497)

$ (181,472)

Capital expenditures

(4,279)

(5,097)

(3,661)

(23,028)

(21,043)

(22,210)

(22,479)

Collections from beneficial interests in securitized trade receivables (5)

41,007

31,741

30,419

188,312

175,911

197,578

177,233

Adjusted Free Cash Flow (1)

$ (458,559)

$ (225,532)

$ (258,916)

$ 151,898

$ (60,102)

$ (81,129)

$ (26,718)



(1)

Earnings before interest, taxes, depreciation and amortization ("EBITDA"), adjusted earnings before interest, taxes, depreciation and amortization ("Adjusted EBITDA"), Adjusted Free Cash Flow, and Net Debt are not measures of results of operations, cash flows from operations or indebtedness under generally accepted accounting principles in the United States ("U.S. GAAP") and should not be considered as an alternative to other U.S. GAAP measurements. We have presented EBITDA, Adjusted EBITDA, Adjusted Free Cash Flow, and Net Debt to adjust for the items identified above because we believe that it would be helpful to the readers of our financial information to understand the impact of these items on our reported amounts. This presentation enables readers to better compare our results to similar companies that may not incur the impact of various items identified above. Management acknowledges that there are many items that impact a company's reported results or operating cash flows and these lists are not intended to present all items that may have impacted these items. EBITDA, Adjusted EBITDA, Adjusted Free Cash Flow, Net Debt, and any ratios calculated based on these measures are not necessarily comparable to similarly-titled measures used by other companies or appearing in our debt obligations or agreements. EBITDA, Adjusted EBITDA and Adjusted Free Cash Flow as presented may not equal column or row totals due to rounding.

(2)

Amounts incurred during the fiscal year ended March 31, 2025 included employee separation charges primarily related to the continued restructuring of certain leaf operations. Amounts incurred during the fiscal year ended March 31, 2024 included employee separation charges primarily related to changes in the corporate organizational structure and the continued restructuring of certain leaf operations and asset impairment charges primarily related to continued restructuring of certain non-leaf agriculture operations.

(3)

During the fiscal year ended March 31, 2024, the Company terminated one of its defined benefit pension plans in the U.K. ("U.K. Pension Plan"). The Company recorded a noncash pension settlement charge which included the disposition of the U.K. Pension Plan assets and reclassification of unrecognized net pension losses within accumulated other comprehensive income (loss) into the Company's condensed consolidated statements of operations.

(4)

Includes the following items: (i) the addition of amortization of basis difference related to a former Brazilian subsidiary that is now deconsolidated following the completion of a joint venture in March 2014, (ii) the subtraction of the Adjusted EBITDA of the Company's former green leaf sourcing operation in Kenya, which is calculated on the same basis as Adjusted EBITDA presented in this table (in fiscal year 2016 the Company decided to exit green leaf sourcing in the Kenyan market as part of our restructuring program), and (iii) the subtraction of the Adjusted EBITDA of the industrial hemp operations, which is calculated on the same basis as Adjusted EBITDA presented in this table.

(5)

Represents cash receipts from the beneficial interest on sold receivables under the Company's accounts receivable securitization programs and are classified as investing activities within the condensed consolidated statements of cash flows.

(6)

Items for the twelve months ended June 30, 2025 are derived by adding the items for the three months ended June 30, 2025 as presented in the table and the fiscal year ended March 31, 2025 and subtracting the items for the three months ended June 30, 2024. Items for the twelve months ended June 30, 2024 are derived by adding the items for the three months ended June 30, 2024 as presented in the table and the fiscal year ended March 31, 2024 and subtracting the items for the three months ended June 30, 2023.

SOURCE Pyxus International, Inc.

© 2025 PR Newswire
Tech-Aktien mit Crash-Tendenzen
Künstliche Intelligenz, Magnificent Seven, Tech-Euphorie – seit Monaten scheint an der Börse nur eine Richtung zu existieren: nach oben. Doch hinter den Rekordkursen lauert eine gefährliche Wahrheit. Die Bewertungen vieler Tech-Schwergewichte haben historische Extremniveaus erreicht. Shiller-KGV bei 39, Buffett-Indikator auf Allzeithoch – schon in der Dotcom-Ära war der Markt kaum teurer.

Hinzu kommen euphorische Anlegerstimmung, IPO-Hypes ohne Substanz, kreditfinanzierte Wertpapierkäufe in Rekordhöhe und charttechnische Warnsignale, die Erinnerungen an 2000 und 2021 wecken. Gleichzeitig drücken geopolitische Risiken, Trumps aggressive Zollpolitik und saisonale Börsenschwäche auf die Perspektiven.

Die Gefahr: Aus der schleichenden Korrektur könnte ein rasanter Crash werden – und der könnte vor allem überbewertete KI- und Chipwerte hart treffen.

In unserem kostenlosen Spezial-Report zeigen wir Ihnen, welche Tech-Aktien am stärksten gefährdet sind und wie Sie Ihr Depot vor dem Platzen der Blase schützen könnten.

Holen Sie sich den neuesten Report!

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.